Evidence map›Paper›PMID 31137836›Full record

ArticleViruses2019

Limited Sustained Local Transmission of HIV-1 CRF01_AE in New South Wales, Australia.

Francesca Di Giallonardo, Angie N Pinto, Phillip Keen, Ansari Shaik, Alex Carrera, Hanan Salem, Barbara Telfer, Craig Cooper, Karen Price, Christine Selvey and 8 more

Abstract read
In one paragraph

Article in Viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Francesca Di GiallonardoThe Kirby Institute, The University of New South Wales, Sydney, New South Wales 2052, Australia. fdigiallonardo@kirby.unsw.edu.au.
Angie N PintoThe Kirby Institute, The University of New South Wales, Sydney, New South Wales 2052, Australia. apinto@kirby.unsw.edu.au.ORCID 0000-0003-3583-9490
Phillip KeenThe Kirby Institute, The University of New South Wales, Sydney, New South Wales 2052, Australia. pkeen@kirby.unsw.edu.au.ORCID 0000-0002-2678-0645
Ansari ShaikThe Kirby Institute, The University of New South Wales, Sydney, New South Wales 2052, Australia. ashaik@kirby.unsw.edu.au.
Alex CarreraNew South Wales State Reference Laboratory for HIV/AIDS, Darlinghurst, New South Wales 2010, Australia. alex.carrera@svha.org.au.
Hanan SalemNew South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia. hanan.salem@health.nsw.gov.au.
Barbara TelferHealth Protection New South Wales, New South Wales Health, NSW, North Sydne, New South Wales 2060, Australia. barbara.telfer@health.nsw.gov.au.
Craig CooperPositive Life New South Wales, Surry Hills, New South Wales 2010, Australia. craigc@positivelife.org.au.
Karen PriceACON Health Ltd., Surry Hills, New South Wales 2010, Australia. kprice@acon.org.au.
Christine SelveyHealth Protection New South Wales, New South Wales Health, NSW, North Sydne, New South Wales 2060, Australia. christine.selvey@health.nsw.gov.au.
Joanne HoldenCentre for Population Health, New South Wales Ministry of Health, North Sydney, New South Wales 2059, Australia. jo.holden@health.nsw.gov.au.
Nadine BachmannDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Institute of Medical Virology, University of Zurich, 8091 Zurich, Switzerland. nadine.bachmann2@usz.ch.
Frederick J LeeNew South Wales Health Pathology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia. frederick.lee@health.nsw.gov.au.
Dominic E DwyerNew South Wales Health Pathology-Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales 2145, Australia. dominic.dwyer@sydney.edu.au.
Sebastián DuchêneDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Victoria 3000, Australia. sebastian.duchene@unimelb.edu.au.
Edward C HolmesSydney Medical School, University of Sydney, Sydney, New South Wales 2006, Australia. edward.holmes@sydney.edu.au.ORCID 0000-0001-9596-3552
Andrew E GrulichThe Kirby Institute, The University of New South Wales, Sydney, New South Wales 2052, Australia. agrulich@kirby.unsw.edu.au.
Anthony D KelleherThe Kirby Institute, The University of New South Wales, Sydney, New South Wales 2052, Australia. akelleher@kirby.unsw.edu.au.

Funding

Swiss National Science Foundation P300PA_174462
6 · The paper itself

Abstract

Australia's response to the human immunodeficiency virus type 1 (HIV-1) pandemic led to effective control of HIV transmission and one of the world's lowest HIV incidence rates-0.14%. Although there has been a recent decline in new HIV diagnoses in New South Wales (NSW), the most populous state in Australia, there has been a concomitant increase with non-B subtype infections, particularly for the HIV-1 circulating recombinant form CRF01_AE. This aforementioned CRF01_AE sampled in NSW, were combined with those sampled globally to identify NSW-specific viral clades. The population growth of these clades was assessed in two-year period intervals from 2009 to 2017. Overall, 109 NSW-specific clades were identified, most comprising pairs of sequences; however, five large clades comprising ≥10 sequences were also found. Forty-four clades grew over time with one or two sequences added to each in different two-year periods. Importantly, while 10 of these clades have seemingly discontinued, the remaining 34 were still active in 2016/2017. Seven such clades each comprised ≥10 sequences, and are representative of individual sub-epidemics in NSW. Thus, although the majority of new CRF01_AE infections were associated with small clades that rarely establish ongoing chains of local transmission, individual sub-epidemics are present and should be closely monitored.

Indexed as

HIV-1Evolution, MolecularGenotypeHigh-Throughput Nucleotide SequencingHIV InfectionsHumansNew South WalesPhylogenyPublic Health Surveillancecluster growthevolutionHIV-1 CRF01_AEsub-epidemictransmission cluster

Identifiers

PMID31137836
PMCPMC6563510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.